...
首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
【24h】

Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.

机译:治疗腹腔出血重组激活因子VII病人弥漫性血管内凝血继发于感染性休克。

获取原文
获取原文并翻译 | 示例

摘要

Although mainly indicated for treatment of bleeding in haemophilia patients with inhibitors, recombinant activated factor VII (rFVIIa) has also been successfully used in other situations. However, no data are available on its use in the treatment of disseminated intravascular coagulation (DIC) secondary to septic shock. We report a man with DIC and septic shock due to retrocaecal appendicitis and severe intra-abdominal bleeding after surgery. Despite conventional treatment, the bleeding persisted, and treatment with rFVIIa controlled the haemorrhage. No side-effects related to rFVIIa were noted. This case suggests a potential role of rFVIIa in the treatment of severe bleeding associated with DIC.
机译:尽管主要表示接受治疗血友病患者的出血与抑制剂,重组激活因子VII (rFVIIa)在其他情况下也被成功使用。然而,没有数据可用使用播散性血管内治疗凝固(DIC)继发于感染性休克。报告DIC和感染性休克retrocaecal阑尾炎和严重手术后腹腔出血。常规治疗,出血持续,与rFVIIa控制和治疗出血。被指出。rFVIIa治疗严重的出血与迪拜国际资本有关。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号